Bioscience

Arizona Bioscience News: ASU, Tempe to study opioids in wastewater; UA announces tech park plans; TGen developing cancer blood test

May 31, 2018

By Amy Pitney

Cardon Children’s opens Valley’s first clinic to treat neuropsychiatric disorders / AZ Big Media

Cardon Children’s Medical Center’s new clinic, a partnership between Banner Health and the University of Arizona Steele Children’s Research Center, in Mesa is only the second of its kind in the U.S. to treat and conduct research into neuropsychiatric disorders that historically have been misdiagnosed or undiagnosed in children.

Both UA Tech Parks in Tucson move ahead with hotel, office and residential plans / Arizona Daily Star

The University of Arizona announced plans for office buildings at the UA Tech Park at the Bridges, including the Innovation and Technology Complex that will house Tech Launch Arizona, and planning is underway for a mixed-use development for the Tech Park on Rita Road. Read more: Development underway at two sites for UA Tech Parks

Tempe, ASU to study wastewater for clues about opioid use / Cronkite News

Arizona State University scientists will work with the city of Tempe to detect opioids, cocaine, marijuana and other drugs in city wastewater as part of an effort to monitor public health. Read more: Tempe partners with ASU to detect drugs in wastewater

New UA research will study link between stress and pain / KJZZ

Scientists from the University of Arizona have received a nearly $3 million grant from the National Institute of Neurological Disorders and Stroke to understand how stress can trigger pain.

Blood test developed in Phoenix area showing promise in detecting cancer / azfamily.com

Researchers at TGen have come up with a simple blood test that can detect cancer cells quickly and without the invasiveness of a biopsy by looking for molecular biomarkers found in melanoma, bile duct cancer, rectal cancer and breast cancer.

UA student presents research on opioid prevention in Washington, D.C. / KJZZ

University of Arizona’s Lindsey Chew recently returned from Washington, D.C. where she shared research from a UA lab with lawmakers on Capitol Hill.

First-ever migraine treatment approved by FDA included Scottsdale Mayo Clinic trial / KJZZ

The FDA approved the first treatment aimed at preventing migraines after a nationwide trial which included the Mayo Clinic in Scottsdale.